I agree that not only would new partners insist on
Post# of 148185
(Total Views: 553)
Posted On: 04/13/2022 8:27:49 PM
I agree that not only would new partners insist on closure via settlement or judgement, but that from CYDY's perspective, millions spent now to clean this mess up will be worth billions in future negotiations.
I suspect that NP being NP, screwed the pooch on more than one occasion, while trying to expediate. ( a man trying to advance his beliefs in a better medicine contributing to a better outcome for those lacking hope) vs Amarex (we see where we can profit from his over eagerness to getter done). Even academics are human beings. Amarex & NSF are surprisingly stupid for not settling quickly, IMO.
The "8- 12 weeks" I heard on the CC addressing some timeline will probably catch a few of tEEhem as I suspect that once things are in order it will be rapid fire.
Feel like NASH & LH are already agreed upon & waiting. Multiple combos soon after.
Hope Brazil trials continue. Was disappointed by enrollment numbers, but after going back to trial requirements was not surprised. Not AE, but our own criteria for enrollment. Given that it seems CR has really zeroed in on the target, maybe 50 is not such a low number. He needs the chance to see if he is on target.Prospective partners in indications other than NASH & cancer may be swayed by data from these trials. FDA & potential partners may breathe a sigh of relief if a well -run trial from anyone not named Amarex that confirms that LL is safe.
If CYDY is to pursue combo-therapy it will be important to have much data as to the safety of LL in monotherapy if there were to be SAE in combo-therapy ( we know the culprit)
Do not forget - BP has to sell it to their investors.
I suspect that NP being NP, screwed the pooch on more than one occasion, while trying to expediate. ( a man trying to advance his beliefs in a better medicine contributing to a better outcome for those lacking hope) vs Amarex (we see where we can profit from his over eagerness to getter done). Even academics are human beings. Amarex & NSF are surprisingly stupid for not settling quickly, IMO.
The "8- 12 weeks" I heard on the CC addressing some timeline will probably catch a few of tEEhem as I suspect that once things are in order it will be rapid fire.
Feel like NASH & LH are already agreed upon & waiting. Multiple combos soon after.
Hope Brazil trials continue. Was disappointed by enrollment numbers, but after going back to trial requirements was not surprised. Not AE, but our own criteria for enrollment. Given that it seems CR has really zeroed in on the target, maybe 50 is not such a low number. He needs the chance to see if he is on target.Prospective partners in indications other than NASH & cancer may be swayed by data from these trials. FDA & potential partners may breathe a sigh of relief if a well -run trial from anyone not named Amarex that confirms that LL is safe.
If CYDY is to pursue combo-therapy it will be important to have much data as to the safety of LL in monotherapy if there were to be SAE in combo-therapy ( we know the culprit)
Do not forget - BP has to sell it to their investors.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼